Evolution Wealth Advisors, LLC Incyte Corp Transaction History

Evolution Wealth Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$63.34 - $74.11 $1,330 - $1,556	-21 Closed	0 $0
Q2 2020 Jul 27, 2020	BUY	$74.18 - $108.93 $1,557 - $2,287	21 New	21 $2,000
Q1 2020 Apr 22, 2020	SELL	$63.18 - $85.97 $2,527 - $3,438	-40 Closed	0 $0
Q4 2019 Feb 03, 2020	BUY	$73.04 - $95.72 $1,022 - $1,340	14 Added 53.85%	40 $3,000
Q3 2019 Nov 12, 2019	BUY	$72.82 - $86.52 $436 - $519	6 Added 30.0%	26 $2,000
Q2 2019 Jul 12, 2019	BUY	$73.52 - $88.7 $1,470 - $1,774	20 New	20 $2,000

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.